Inga Melchers

Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.

W. Lehmacher, M. Meurer, U. Müller-Ladner, 2008, Rheumatology.

BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4.

J. Cracowski, P. Dieudé, G. Riemekasten, 2009, Arthritis and rheumatism.

Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype.

H. Wichmann, W. Koenig, P. Dieudé, 2011, Arthritis and rheumatism.

The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase‐1 antibodies

M. Worm, G. Riemekasten, T. Krieg, 2016, The British journal of dermatology.

Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica

M. González-Gay, F. Moosig, T. Witte, 2012, Annals of the rheumatic diseases.

Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients

Manfred, Matthias Schneider, S. Karrer, 2017 .